Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Rev. méd. Chile ; 136(7): 921-929, jul. 2008. tab
Artigo em Espanhol | LILACS | ID: lil-496016

RESUMO

Gastrointestinal stromal tumors (GIS) are a heterogeneous group of tumors that express CD 117 molecule in their sur face. They may behave as benign tumors or be highly aggressive. A better survival of patients with these tumors has been achieved using the new molecular therapies such as imatinib mesylate, sunitinib and others. This review analyzes the prognostic factors of these tumors, their clinical features and the criteria for malignant behavior. The value of therapeutic alternatives such as radiotherapy chemotherapy and the new molecular therapies are also discussed.


Assuntos
Humanos , Tumores do Estroma Gastrointestinal/terapia , Antineoplásicos/uso terapêutico , Tumores do Estroma Gastrointestinal/complicações , Tumores do Estroma Gastrointestinal/diagnóstico , Indóis , Piperazinas/uso terapêutico , Inibidores de Proteínas Quinases/uso terapêutico , Proteínas Tirosina Quinases/uso terapêutico , Proteínas Proto-Oncogênicas c-kit/uso terapêutico , Pirimidinas/uso terapêutico , Pirróis
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA